7/27/2019 Toshiba ACC 2013 Press Release

1/3

TOSHIBA LAUNCHES NEW CARDIAC ULTRASOUND SYSTEMS AT ACCAplio 500 CV and Aplio 300 CV Designed to Improve Cardiac Diagnoses

SAN FRANCISCO, March 8, 2013 To help clinicians more accurately and efficiently diagnose

cardiovascular disease, Toshiba America Medical Systems, Inc. introduces the AplioTM

500 and

Aplio 300 CV ultrasound systems. Compact and easy-to-use, Aplio 500 CV and Aplio 300 CV

deliver exceptional image quality and advanced technologies to improve patient diagnoses and

treatment.

Both the Aplio 500 and 300 CV are the systems of choice for all premium 2D cardiac

exams and feature Toshibas 2D Wall Motion Tracking technology, which provides stunning

visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and

reproducibility. With on-board cardiac quantification measurements in all directions (radial,

circumferential, 2D rotation and longitudinal), the Aplio CV systems are designed to get the most

comprehensive information anytime and anywhere in the hospital, right at the patients bedside.

Additional cardiac-specific technologies include Tissue Enhancement, Advanced

Dynamic Flow, Lateral Gain Controls, Tissue Doppler, Stress Echo, Flex-M Mode and Auto

IMT. Both systems are easy to use, with superior ergonomics and a smaller footprint, making

them easier to maneuver for greater patient access and improved workflow.

Aplio 500 and 300 CV provide picture-perfect images with unprecedented resolution,

and deliver clinical data faster and more reliably, said Tomohiro Hasegawa, director, Ultrasound

Business Unit, Toshiba. Combined with 2D Wall Motion Tracking, physicians can conduct the

best bedside cardiac exams and have access to the most comprehensive quantification

measurements (strain, strain rates or ejection fraction) on-board the systems and in just three

simple clicks.

7/27/2019 Toshiba ACC 2013 Press Release

2/3

Toshiba will showcase Aplio 500 CV and Aplio 300 CV at this years American College of

Cardiology (ACC) annual meeting in San Francisco, March 9 11, 2013 (Booth #5733, North

Hall).

About ToshibaAmerica Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets,

sells, distributes and services radiology and cardiovascular systems, including CT, MR,

ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging

research for all modalities in the United States. For more information, visit the TAMS website at

www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical

diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and

vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for

medical institutions. Toshiba Medical Systems Corporation has been providing medical

products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned

subsidiary of Toshiba.

About Toshiba

Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of

advanced electronic and electrical products and systems. Toshiba Group brings innovation and

imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs,

retail solutions and MFPs; electronic devices, including semiconductors, storage products and

materials; industrial and social infrastructure systems, including power generation systems, smart

community solutions, medical systems and escalators & elevators; and home appliances.

7/27/2019 Toshiba ACC 2013 Press Release

3/3

Toshiba was founded in 1875, and today operates a global network of more than 550

consolidated companies, with 202,000 employees worldwide and annual sales surpassing 6.1

trillion yen (US$74 billion). Visit Toshibas website at www.toshiba.co.jp/index.htm.

###